Table 1.

Baseline characteristics by deprivation index, graft loss and patient mortality

	Overall	Neighborhood Deprivation Index
	N (%) or Median (IQR)
	N = 2530	Low N=1265	High N=1265	p-value
Age at Transplant, years	2.3 (0.8, 9.2)	2.7 (0.9, 10.3)	2.0 (0.8, 7.8)	0.002
Gender
Female	1284 (50.8%)	640 (50.6%)	644 (50.9%)	0.91
Ethnicity
Hispanic	564 (22.3%)	174 (13.8)	390 (30.8%)	<0.001
Race
White	1858 (73.4%)	996 (78.7%)	862 (68.1%)	<0.001
Black	445 (17.6%)	136 (10.8%)	309 (24.4%)
Other	227 (9.0%)	133 (10.5%)	94 (7.4%)
Primary Insurance
Private	1106 (43.7%)	759 (60.0%)	347 (27.4%)	<0.001
Public	1375 (54.3%)	478 (37.8%)	897 (70.9%)
Other	49 (1.9%)	28 (2.2%)	21 (1.7%)
Recipient Diagnosis
Biliary Atresia	798 (31.5%)	398 (31.5%)	400 (31.6%)	0.06
Other cholestatic	493 (19.5%)	233 (18.4%)	260 (20.6%)
Acute Liver Failure	272 (10.8%)	123 (9.7%)	149 (11.8%)
Metabolic	227 (9.0%)	123 (9.7%)	104 (8.2%)
Tumor	214 (8.5%)	119 (9.4%)	95 (7.5%)
Autoimmune Hepatitis	112 (4.4%)	66 (5.2%)	46 (3.6%)
Other	414 (16.4%)	203 (16.0%)	211 (16.7%)
Laboratory MELD/PELD at Transplant	15 (5, 25)	14 (4, 24)	16 (5, 26)	0.08
Allocation MELD/PELD at Transplant	25 (16, 32)	25 (16, 32)	25 (16, 32)	0.45
Status 1a/1b
Yes	739 (29.2%)	362 (28.6%)	377 (29.8%)	0.55
Donor Age at Transplant, years	10 (2, 20)	11 (2, 22)	8 (1, 19)	<0.001
Transplant type
Living Donor Transplant	272 (10.8%)	161 (12.7%)	111 (8.8%)	0.002
Cold Ischemia Time, hours	6.6 (5.0, 8.3)	6.5 (4.8, 8.0)	6.8 (5.0, 8.5)	0.03

Empty cells in p-value columns are because p-value represents comparison across all categories of a variable.

High and low deprivation were classified as above and below the median deprivation index of the cohort, respectively. IQR = interquartile range; MELD: The Model for End-stage Liver Disease; PELD: Pediatric End-stage Liver Disease